About 7 results found for searched term "MR22" (0.163 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6997 | MRS 1220 | Others |
| MRS 1220 is a highly potent, selective hA 3 antagonist. | ||
| M7001 | MRS 2219 | Others |
| MRS 2219 is a potentiates P2X 1-mediated responses. | ||
| M7002 | MRS 2279 | Others |
| MRS 2279 is a selective, high affinity P2Y 1 antagonist. | ||
| M42054 | MR22 | Salt-inducible Kinase |
| MR22 is a potent pan-SIK (salt-inducible kinase) inhibitor. | ||
| M11331 | UC2288 | Mdm2 |
| UC2288 is a novel p21 attenuator with cellular permeability and oral activity (relatively selective activity for P21), based on the structural synthesis of sorafenib. UC2288 down-regulated the expression of P21 mRNA and reduced the level of P21 protein independently of p53, and had little effect on the stability of P21 protein. UC2288 did not inhibit VEGFR2 and Raf kinases, even at 10 μM. | ||
| M15037 | Recombinant Mouse IP-10/CXCL10 (E. coli) | Recombinant Proteins |
| Small inducible cytokine B10; CXCL10 | ||
| Interferon inducible protein 10 (IP-10)/CXCL10 was originally thought to be an IFN-γ- inducible gene in monocytes, fibroblasts, and endothelial cells. LPS, IL-1β, TNF-α, IL-12 and virus can also induce the expression of IP-10 mRNA. Protein structure: CXCL10 (ILE22-PRO98), Accession # :Q548V9. | ||
| M15038 | Recombinant Human IP-10/CXCL10 (E. coli) | Recombinant Proteins |
| Small inducible cytokine B10; CXCL10 | ||
| IP-10 /CXCL10, also known as CXCL10, was originally thought to be an IFN-γ- induced gene in monocytes, fibroblasts, and endothelial cells. LPS, IL-1β, TNF-α, IL-12 and virus can also induce the expression of IP-10 mRNA. Expressed with an N-terminal Met. CXCL10 (VAL22-PRO98), Accession # :P02778. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
